You are here
3P BIOTECHNOLOGIES, INC.
https://www.3Pbiotechnologies.com
UEI: HSCNW2K7VN97
# of Employees: 6
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Engineered Exosomes for Targeted Delivery of the CRISPR/Cas9 Genome-editor
Amount: $264,507.00Technical AbstractGenetic mutations have been identified as a causative factor in numerous diseases. The genome editing system CRISPR/Cas9 is a recent development in gene therapy. Both viral and non-v ...
STTRPhase I2022Department of Health and Human Services National Institutes of Health -
Exosomal Drug Delivery
Amount: $1,719,680.00Technical AbstractAs with many chemotherapeutic drugstaxanes exhibit poor oral bioavailabilityhencethey are administered intravenouslyi vThis regimen results in significant toxicitiesdue to both the h ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Exosomal drug formulations
Amount: $225,000.00DESCRIPTION (provided by applicant): More people in the U.S. (160,340 per year) die of lung cancer than of prostate, breast, and colon cancer combined. The most common type of lung cancer, non-small-c ...
STTRPhase I2014Department of Health and Human Services National Institutes of Health -
Sustained, target delivery for treatment of cervical pathologies
Amount: $300,000.00DESCRIPTION (provided by applicant): Cervical cancer, which is caused by HPV infection, is characterized by the progressive formation of dysplastic lesions, known as cervical intraepithelial neoplasi ...
SBIRPhase I2012Department of Health and Human Services National Institutes of Health